Skip to content

Clinical trials

Hypoglycemia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypoglycemia Clear all

660 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20011
20025
200312
20046
200516
200614
200723
200828
200920
201018
201122
201217
201330
201431
201531
201637
201732
201844
201938
202039
202133
202233
202339
202431
202521
202624

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed432
Terminated52
Recruiting49
Unknown status48
Withdrawn32
Not yet recruiting18
Active, not recruiting13
Suspended5
Enrolling by invitation5
No longer available3
Available3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Institut de Recherches Cliniques de Montreal27
Steno Diabetes Center Copenhagen17
Joslin Diabetes Center14
University of Minnesota13
Insel Gruppe AG, University Hospital Bern12
Yale University11
Zealand Pharma11
Eli Lilly and Company10
Jaeb Center for Health Research10
Xeris Pharmaceuticals10

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypoglycemia660
Diabetes Mellitus, Type 1264
Diabetes Mellitus137
Hyperglycemia110
Diabetes Mellitus, Type 285
Insulin Resistance56
Hyperinsulinism19
Glucose Metabolism Disorders17
Congenital Hyperinsulinism15
Diabetes Complications13

Trials

Showing 76 to 100 of 660. Each trial links to its page on Pharma Observatory.

560 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.